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Background
Atopic dermatitis (AD) in most of infants is associated
with food allergy; cow milk proteins are a main antigen
in 80-90% cases. The aim of study is examination of the
clinical effectiveness of the goat milk-based formula with
prebiotics in infants with AD aged 6-12 months old.
Methods
The examination included 50 formula-fed infants with
AD aged 6-12 months old. The main group (n = 30)
comprised infants, who received the goat milk-based
formula with prebiotics. The reference group (n = 20) –
infants, who received a formula based on soy protein
isolates. All the patients received standard therapy for
AD (antihistamine drugs, local anti-inflammatory ther-
apy, therapeutic and cosmetic skin care, etc.) that did
not differ in both groups. The effectiveness of the admi-
nistered therapy was assessed on the basis of the
dynamics of clinical symptoms of disease according to
SCORAD score, and also by decrease of total IgE level
in serum. The level of total IgE was measured by
immune-enzymometric method using the spectrophot-
ometer “Sunrise” (Belgium).
Results
In the main group, the clinical effectiveness of the formula
with prebiotics based on New Zealand goat milk
amounted to 76.7% (average duration of the exacerbation
period – 13.0 ± 1.5 days, the SCORAD index decreased by
3.7 times – from 30 to 8 scores), in the reference group –
40% (average duration of the exacerbation period – 27.0 ±
1.7 days, the SCORAD index decreased by 2 times – from
34 to 17 scores). The analysis of results of immunologic
evaluation revealed that initial level of serum total IgE was
increased in 82% patients of the main group, mean level
was 260 IU/ml. After therapy the mean level of serum
total IgE decreased by 2.7 times – to 95 IU/ml. In the
reference group initial level of serum total IgE was
increased in 80% patients, after complex therapy it
decreased by 1.8 times – from 262 to 145 IU/ml.
Conclusion
The adapted formula based on goat milk with prebiotics
for 6-12 months old infants may be recommended as a
dietary product for formula-fed infants with AD.
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